Alcoholic Liver Disease Patients Listed for Liver Transplantation: An Overview from 2002-2017

Manasi Joshi, E. Godfrey, J. Goss, A. Rana
{"title":"Alcoholic Liver Disease Patients Listed for Liver Transplantation: An Overview from 2002-2017","authors":"Manasi Joshi, E. Godfrey, J. Goss, A. Rana","doi":"10.17554/j.issn.2224-3992.2020.09.960","DOIUrl":null,"url":null,"abstract":"ALD patients comprise a larger proportion of listings for liver transplant (LT) than in the past, and represent a population undergoing demographic change in the United States. This study examined the OPTN/UNOS transplantation waitlist STAR files from March 2002 - December 2017. All adults listed for LT were included (n=135,956). Yearly demographic trends in ALD-related listings and listing outcomes (transplantation vs. death on waitlist) were explored. Alcoholic cirrhosis has increased from 4.3% of the LT candidates in 2002 to 8.3% in 2017. While alcoholic hepatitis accounted for only 0.64% of listings in 2017, this has doubled since 2004. The proportion of women listed for ALD increased (21.8% in 2002 vs. 28.34% in 2017). Furthermore, proportionally fewer ALD listings are White patients (79.42% in 2002 vs. 75.66% in 2017). While the proportion of Hispanic LT candidates increased (12.87% vs. 15.94% p=0.00), proportionally, Hispanic ALD patients remained constant (15.68%, 15.84%). Since 2015, the percentage of ALD patients on the waitlist receiving transplants increased (from 41% in 2014 to 45% and 49% in 2015 and 2016). This increase is more than the increase for patients transplanted for non-ALD indications (39% to 40% and 41%). Transplant-to-death ratio increased to 7.6 in 2017 in the ALD group but only to 4.3 in the non-ALD group. This descriptive study provides an update on the relative prevalence of ALD in the LT population, demographic changes, and waitlist outcomes.","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"9 1","pages":"3309-3312"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gastroenterology and hepatology research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17554/j.issn.2224-3992.2020.09.960","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ALD patients comprise a larger proportion of listings for liver transplant (LT) than in the past, and represent a population undergoing demographic change in the United States. This study examined the OPTN/UNOS transplantation waitlist STAR files from March 2002 - December 2017. All adults listed for LT were included (n=135,956). Yearly demographic trends in ALD-related listings and listing outcomes (transplantation vs. death on waitlist) were explored. Alcoholic cirrhosis has increased from 4.3% of the LT candidates in 2002 to 8.3% in 2017. While alcoholic hepatitis accounted for only 0.64% of listings in 2017, this has doubled since 2004. The proportion of women listed for ALD increased (21.8% in 2002 vs. 28.34% in 2017). Furthermore, proportionally fewer ALD listings are White patients (79.42% in 2002 vs. 75.66% in 2017). While the proportion of Hispanic LT candidates increased (12.87% vs. 15.94% p=0.00), proportionally, Hispanic ALD patients remained constant (15.68%, 15.84%). Since 2015, the percentage of ALD patients on the waitlist receiving transplants increased (from 41% in 2014 to 45% and 49% in 2015 and 2016). This increase is more than the increase for patients transplanted for non-ALD indications (39% to 40% and 41%). Transplant-to-death ratio increased to 7.6 in 2017 in the ALD group but only to 4.3 in the non-ALD group. This descriptive study provides an update on the relative prevalence of ALD in the LT population, demographic changes, and waitlist outcomes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2002-2017年酒精性肝病肝移植患者名单综述
ALD患者在肝移植(LT)名单中所占比例比过去更大,代表了美国正在经历人口结构变化的人群。本研究检查了2002年3月至2017年12月的OPTN/UNOS移植等待名单STAR文件。纳入所有列为LT的成年人(n=135956)。对ALD相关列表和列表结果(移植与等待名单上的死亡)的年度人口统计趋势进行了探讨。酒精性肝硬化已从2002年的4.3%上升到2017年的8.3%。虽然2017年酒精性肝炎仅占上市公司的0.64%,但自2004年以来,这一比例翻了一番。被列入ALD名单的女性比例有所上升(2002年为21.8%,2017年为28.34%)。此外,白人患者的ALD列表按比例减少(2002年为79.42%,2017年为75.66%)。虽然西班牙裔LT候选患者的比例有所增加(12.87%对15.94%,p=0.00),但西班牙牙裔ALD患者的比例保持不变(15.68%,15.84%)。自2015年以来,等待接受移植的ALD患者比例有所上升(从2014年的41%上升到2015年和2016年的45%和49%)。这一增长超过了非ALD适应症移植患者的增长(39%至40%和41%)。2017年,ALD组的移植死亡率增至7.6,但非ALD组仅增至4.3。这项描述性研究提供了LT人群中ALD相对患病率、人口结构变化和等待名单结果的最新情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Changing liver stiffness predict regression in advanced fibrosis patients with chronic hepatitis B, but not in moderate fibrosis patients Effect of Zangfu ointment and massage therapy on functional constipation: a protocol for a randomised controlled trial Classification of metabolic-associated fatty liver disease subtypes based on TCM clinical phenotype A review on conventional and herbal drug approach to peptic ulcer Efficacy and safety of Banxia Xiexin Decoction in the treatment of gastric ulcer: a systematic review and meta-analysis of twenty-seven randomized controlled trials
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1